Delaware Valley Floral Group has been acquired by Staple Street Capital
The owners of Delaware Valley Floral Group, Inc. (DVFG) have sold the company to Staple Street Capital.
Founded in 1959 by the Wilkins family, Delaware Valley Floral Group is a third-generation family-owned business, and the family will continue to hold a significant stake post-close. DVFG offers the industry’s broadest assortment of fresh cut flowers and floral supplies to thousands of independent retail florists and supermarket customers. Headquartered in Sewell, New Jersey, the group leverages a regional hub-and-spoke distribution network, comprised of 11 strategically located distribution centers, combined with cold chain infrastructure and multi-state direct store delivery capabilities to serve as a mission critical partner to its suppliers and customers.
Headquartered in New York City, Staple Street Capital is a private equity firm with approximately US$900 million of capital under management which invests in market-leading businesses where there are transformational opportunities to create value.
Oaklins TM Capital in the US served as the exclusive financial advisor to Delaware Valley Floral Group, Inc. in its sale to Staple Street Capital.
Jack Chidester
CEO, Delaware Valley Floral Group, Inc.
Contáctese con el equipo de la transacción
Michael S. Goldman
Oaklins TM Capital
Michael L. Bauman
Oaklins TM Capital
Transacciones relacionadas
ABZ Seeds has been acquired by Planasa
ABZ Seeds, a renowned breeder of seed-propagated F1 hybrid strawberry varieties, has been acquired by Planasa, a global leader in breeding next-generation berry varieties, including blueberries, blackberries, raspberries and strawberries.
Ver másDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Ver másXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Ver más